Associations between inflammatory bowel diseases and vitamin D

References

• Abautret-Daly, Á., E. Dempsey, S. Riestra, R. de Francisco-García, A. Parra-Blanco, L. Rodrigo, C. Medina, T. J. Connor, and A. Harkin. 2017. Association between psychological measures with inflammatory anddisease-related markers of inflammatory bowel disease. Int J Psychiatry Clin Pract. 1–10.
   Web of Science ®Google Scholar
• Abreu-Delgado, Y., R. A. Isidro, and E. A. Torres. 2016. Serum vitamin D and colonic vitamin D receptor in inflammatory bowel disease. World J Gastroenterol. 22:3581–91.
   PubMed Web of Science ®Google Scholar
• Al-Jaderi, Z., and A. A. Maghazachi. 2013. Effects of vitamin D3, calcipotriol and FTY720 onthe expression of surface moleculesand cytolytic activities of human natural killer cells and dendritic cells. Toxins (Basel). 5:1932–47.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan, A. N., A. Cagan, V. S. Gainer, T. Cai, S.-C. Cheng, G. Savova, P. Chen, P. Szolovits, Z. Xia, and P. L. De Jager. 2013. Normalization of Plasma 25-hydroxy Vitamin D is Associated with Reduced Risk of Surgery in Crohn's Disease. Inflammatory Bowel Diseases. 19:1921–1927.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan, A. N., S. C. Cheng, T. Cai, A. Cagan, V. S. Gainer, P. Szolovits, S. Y. Shaw, S. Churchill, E. W. Karlson, and S. N. Murphy. 2014. Association Between Reduced Plasma 25- Hydroxy Vitamin D and Increased Risk of Cancer in Patients With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology. 12:821–827.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan, A. N., H. Khalili, L. M. Higuchi, Y. Bao, J. R. Korzenik, E. L. Giovannucci, J. M. Richter, C. S. Fuchs, and A. T. Chan. 2012. Higher Predicted Vitamin D Status Is Associated With Reduced Risk of Crohn's Disease. Gastroenterology. 142:482–489.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan, A. N. 2016. Vitamin D and Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 12:513–515.
   PubMedGoogle Scholar
• Ananthakrishnan, A. N. 2015. Epidemiology and risk factors for IBD. Nat. Rev. Gastroenterol. Hepatol. 12:205–17.
   Google Scholar
• Ardesia, M., G. Ferlazzo, and W. Fries. 2015. Vitamin D and inflammatory bowel disease. Biomed Res Int. 470805 Review
   PubMed Web of Science ®Google Scholar
• Bamias, G., E. Filidou, D. Goukos, V. Valatas, K. Arvanitidis, M. Panagopoulou, G. Kouklakis, G. L. Daikos, S. D. Ladas, and G. Kolios. 2017. Crohn's disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells. Transl Res. 180:118–130.e2.
   PubMed Web of Science ®Google Scholar
• Barbalho, S. M., M. D. Bechara, R. de Alvares Goulart, K. Quesada, R. G. Gasparini, de Cássio Alves, A. de Carvalho, and A. M. Fiorini. 2016. Reflections About Inflammatory Bowel Disease and Vitamins A and D. J Med Food. 19:1105–1110 Review
   PubMed Web of Science ®Google Scholar
• Bartels, L. E., S. P. Jørgensen, M. Bendix, C. L. Hvas, J. Agnholt, R. Agger, and J. F. Dahlerup. 2013. 25hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohns disease. Inflammopharmacology. 21:177–86.
   PubMed Web of Science ®Google Scholar
• Bittner, S., G. Knoll, and M. Ehrenschwender. 2017. Death receptor 3 signaling enhances proliferation of human regulatory T cells. FEBS Lett. 591:1187–1195.
   PubMed Web of Science ®Google Scholar
• Bora, S., and M. T. Cantorna. 2017. The role of UVR and vitamin D on T cells and inflammatory bowel disease. Photochem Photobiol Sci. 16:347–353.
   PubMed Web of Science ®Google Scholar
• Burisch, J., T. Jess, M. Martinato, and P. L. Lakatos. 2013. The burden of inflammatory bowel disease in Europe. J Crohns Colitis 7:322–37.
   PubMed Web of Science ®Google Scholar
• Calderón-Gómez, E., H. Bassolas-Molina, R. Mora-Buch, I. Dotti, N. Planell, M. Esteller, M. Gallego, M. Martí, C. Garcia-Martín, C. Martínez-Torró, I. Ordás, S. Singh, J. Panés, D. Benítez-Ribas, and A. Salas. 2016. Commensal-Specific CD4(+) Cells From Patients With Crohn's Disease Have a T-Helper 17 Inflammatory Profile. Gastroenterology. 151:489–500.e3.
   PubMed Web of Science ®Google Scholar
• Canning, M. O., K. Grotenhuis, and H. de Wit. 2001. 1-alpha, 25-Dihydroxyvitamin D3 (1, 25 (OH)(2) D (3) hampers the maturation of fully active immature dendritic cells from monocytes. European Journal of Endocrinology. 145:351–357.
   PubMed Web of Science ®Google Scholar
• Cantorna, M. T. 2016. IBD:Vitamin D and IBD: moving towards clinical trials. Nat Rev Gastroenterol Hepatol. 13:322–3.
   PubMed Web of Science ®Google Scholar
• Cantorna, M. T. 2012. Vitamin D, multiple sclerosis and inflammatory bowel disease. Archives of biochemistry and biophysics. 523:103–6.
   PubMed Web of Science ®Google Scholar
• Carlsen, K., C. Jakobsen, T. Kallemose, A. Paerregaard, L. B. Riis, P. Munkholm, and V. Wewer. 2017. F-calprotectin and blood markers correlate to Quality of Life in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 4. Epub ahead of print
   Google Scholar
• Castro, F. D., J. Magalhães, P. B. Carvalho, M. J. Moreira, P. Mota, and J. Cotter. 2015. Lower levels of vitamin d correlate with clinical disease activity and quality of life in inflammatory bowel disease. Arq Gastroenterol. 52:260–5.
   PubMedGoogle Scholar
• Chen, J., D. Bruce, and M. T. Cantorna. 2014. Vitamin D receptor expression controls proliferation of na¨ıve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation. BMC Immunology. 15:1–11.
   PubMed Web of Science ®Google Scholar
• Chun, R. F., P. T. Liu, R. L. Modlin, J. S. Adams, and M. Hewison. 2014. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Frontiers in Physiology. 5
   PubMed Web of Science ®Google Scholar
• Colombel, J. F., F. Rutgeerts, W. Reinisch, D. Esser, Y. Wang, and Y. Lang. 2011. Early mucosal healing with infliximab is associated with improved long‐term clinical outcomes in ulcerative colitis. Gastroenterology. 141:1194–1201.
   PubMed Web of Science ®Google Scholar
• Cooney, R., J. Baker, O. Brain, B. Danis, T. Pichulik, P. Allan, D. J. Ferguson, B. J. Campbell, D. Jewell, and A. Simmons. 2010. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med. 6:90–7.
   Google Scholar
• Dimitrov, V., and J. H. White. 2017. Vitamin D signaling in intestinal innate immunity and homeostasis. Mol Cell Endocrinol. 453:68–78.
   PubMed Web of Science ®Google Scholar
• Elia, P. P., Y. F. Tolentino, C. Bernardazzi, and H. S. de Souza. 2015. The role of innate immunity receptors in the pathogenesis of inflammatory bowel disease. Mediators Inflamm. 936193.
   PubMed Web of Science ®Google Scholar
• Elimrani, I., J. Koenekoop, S. Dionne, V. Marcil, E. Delvin, E. Levy, and E. G. Seidman. 2017. Vitamin D Reduces Colitis- and Inflammation-Associated Colorectal Cancer in Mice Independent of NOD2. Nutr Cancer. 69:276–288.
   PubMed Web of Science ®Google Scholar
• Frigstad, S. O., M. Høivik, J. Jahnsen, S. R. Dahl, M. Cvancarova, T. Grimstad, I. P. Berset, G. Huppertz-Hauss, Ø. Hovde, R. Torp, T. Bernklev, B. Moum, and L. P. Jelsness-Jørgensen. 2017. Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol. 52:100–106.
   PubMed Web of Science ®Google Scholar
• Fuss, I. J., F. Heller, M. Boirivant, F. Leon, M. Yoshida, S. Fichtner-Feigl, Z. Yang, M. Exley, A. Kitani, and R. S. Blumberg. 2004. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 the response in ulcerative colitis. The Journal of clinical investigation. 113:1490–7.
   PubMed Web of Science ®Google Scholar
• Gallone, G., W. Haerty, G. Disanto, S. V. Ramagopalan, C. P. Ponting, and A. J. Berlanga-Taylor. 2017. Identification of genetic variants affecting vitamin D receptor binding and associations with autoimmune disease. Hum Mol Genet. 26:2164–2176.
   PubMed Web of Science ®Google Scholar
• Garg, M., O. Rosella, G. Rosella, Y. Wu, J. S. Lubel, and P. R. Gibson. 2017. Evaluation of a 12-week targeted vitamin D supplementation regimen in patients with active inflammatory bowel disease. Clin Nutr. pii: S0261-5614(17)30222-4
   PubMed Web of Science ®Google Scholar
• Ghaly, S., K. Murray, A. Baird, K. Martin, R. Prosser, J. Mill, L. A. Simms, P. H. Hart, G. Radford-Smith, P. A. Bampton, and I. C. Lawrance. 2016. High Vitamin D-Binding Protein Concentration, Low Albumin, and Mode of Remission Predict Relapse in Crohn's Disease. Inflamm Bowel Dis. 22:2456–64.
   PubMed Web of Science ®Google Scholar
• Goulart, R. A., S. M. Barbalho, R. G. Gasparini, and A. C. C. Carvalho. 2016. Facing Terminal Ileitis: Going Beyond Crohn's Disease. Gastroenterol Res. 9:1–9.
   PubMed Web of Science ®Google Scholar
• Han, Y. M., H. Yoon, S. Lim, M. K. Sung, C. M. Shin, Y. S. Park, N. Kim, D. H. Lee, and J. S. Kim. 2017. Risk Factors for Vitamin D, Zinc, and Selenium Deficiencies in Korean Patients with Inflammatory Bowel Disease. Gut Liver. 11:363–369.
   PubMed Web of Science ®Google Scholar
• Iida, T., K. Onodera, and H. Nakase. 2017. Role of autophagy in the pathogenesis of inflammatory bowel disease. World J Gastroenterol. 23:1944–1953.
   PubMed Web of Science ®Google Scholar
• Jaime, F., M. C. Riutort, M. Alvarez-Lobos, R. Hoyos-Bachiloglu, C. A. Camargo, Jr., and A. Borzutzky. 2017. Solar radiation is inversely associated with inflammatory bowel disease admissions. Scand J Gastroenterol. 52:730–737.
   PubMed Web of Science ®Google Scholar
• Kabbani, T. A., I. E. Koutroubakis, R. E. Schoen, C. Ramos-Rivers, N. Shah, J. Swoger, M.1. Regueiro, A. Barrie, M. Schwartz, J. G. Hashash, L. Baidoo, M. A. Dunn, and D. G. Binion. 2016. Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study. Am J Gastroenterol. 111:712–9.
   PubMed Web of Science ®Google Scholar
• Khoo, A. L., L. Chai, and H. Koenen. 2011. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clinic Exp Immunol. 164:72–79.
   PubMed Web of Science ®Google Scholar
• Kuhne, H., A. Schutkowski, and S. Weinholz. 2014. Vitamin D recep- ¨ tor regulates intestinal proteins involved in cell proliferation, migration and stress response. Lipids in Health and Disease. 13
   PubMed Web of Science ®Google Scholar
• Li, J., A. Ueno, and M. Fort Gasia. 2016. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease. Inflamm Bowel Dis. 22:1779–92.
   PubMed Web of Science ®Google Scholar
• Liu, Z., F. Kong, J. E. Vallance, E. Harmel-Laws, S. Amarachintha, K. A. Steinbrecher, M. J. Rosen, and S. Bhattacharyya. 2017. Activation of TGF-βactivated kinase 1 promotes colon mucosal pathogenesis in inflammatory bowel disease. Physiol. Rep 5 pii: e13181
   Web of Science ®Google Scholar
• Makishima, M., T. T. Lu, W. Xie, G. K. Whitfield, H. Domoto, and R. M. Evans. 2002. Vitamin D receptor as an intestinal bile acid sensor. Science. 296:1313–6.
   PubMed Web of Science ®Google Scholar
• Martinet, L., and M. J. Smyth. 2015. Balancing natural killer cell activation through paired receptors. Nat Rev Immunol. 15:243–54.
   PubMed Web of Science ®Google Scholar
• Mattner, F., S. Smiroldo, and F. Galbiati. 2000. Inhibition of Th1 development and treatment of chronic relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analog of 1, 25-dihydroxyvitamin D3. Europ J Immunol. 30:498–508.
   PubMed Web of Science ®Google Scholar
• Meeker, S., A. Seamons, L. Maggio-Price, Paik, and J.. 2016. Protective links between vitamin D, inflammatory bowel disease and colon cancer. World J Gastroenterol. 22:933–48.
   PubMed Web of Science ®Google Scholar
• Mohammed Alhassan, H., A. Mirshafiey, H. Vahedi, G. Hemmasi, Moussavi, A. Nasl Khameneh, K. Parastouei, and A. A. Saboor-Yaraghi. 2017. Immunoregulation of inflammatory and inhibitory cytokines by Vitamin D3 in patients with inflammatory bowel diseases (IBD). Scand J Immunol. 85:386–394.
   PubMed Web of Science ®Google Scholar
• Narula, N., M. Cooray, R. Anglin, Z. Muqtadir, A. Narula, and J. K. Marshall. 2017. Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn's Disease in Remission: A Pilot Randomized Double-Blind Controlled Study. Dig Dis Sci. 62:448–455.
   PubMed Web of Science ®Google Scholar
• Ng, S. C., H. Y. Shi, N. Hamidi, F. E. Underwood, W. Tang, E. I. Benchimol, R. Panaccione, S. Ghosh, J. C. Y. Wu, F. K. L. Chan, J. J. Y. Sung, and G. G. Kaplan. 2017. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet pii: S0140-6736(17)32448-0. doi: 10.1016/S0140-6736(17)32448-0.
   Google Scholar
• Ooi, J. H., Y. Li, C. J. Rogers, and M. T. Cantorna. 2013. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J. Nutr. 143:1679–1686.
   PubMed Web of Science ®Google Scholar
• Ordás, I., L. Eckmann, M. Talamini, D. C. Baumgart, and W. J. Sandborn. 2012. Ulcerative colitis. Lancet. 380:1606–19.
   PubMed Web of Science ®Google Scholar
• Pallav, K., D. Riche, W. L. May, P. Sanchez, and N. K. Gupta. 2017. Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective. World J Gastroenterol. 23:638–645.
   PubMed Web of Science ®Google Scholar
• Papamichael, K., K. A. Chachu, R. Vajravelu, B. P. Vaughn, J. Ni, M. T. Osterman, and A. S. Cheifetz. 2017. Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab. Clin Gastroenterol Hepatol. pii: S1542-3565(17)30385-3 ( ???? Vol)
   Web of Science ®Google Scholar
• Pols, T. W. H., T. Puchner, H. I. Korkmaz, M. Vos, M. R. Soeters, and C. J. M. de Vries. 2017. Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor. PLoS One. 12:e0176715.
   PubMed Web of Science ®Google Scholar
• Raftery, T., A. R. Martineau, C. L. Greiller, S. Ghosh, D. McNamara, K. Bennett, J. Meddings, and M. O'Sullivan. 2015. Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn's disease: Results from a randomised double-blind placebo-controlled study. United European Gastroenterology Journal. 3:294–302.
   PubMed Web of Science ®Google Scholar
• Raftery, T., M. Merrick, M. Healy, N. Mahmud, C. O'Morain, S. Smith, D. McNamara, and M. O'Sullivan. 2015. Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn's Disease in Clinical Remission. Digestive Diseases and Sciences. 60:2427–2435.
   PubMed Web of Science ®Google Scholar
• Rahbour, G., J. Warusavitarne, A. L. Hart, P. J. Tozer, M. R. Ullah, G. P. Thomas, S. M. Gabe, S. C. Knight, H. O. Al-Hassi, and C. J. Vaizey. 2017. Pilot study of immunological factors in non-inflammatory bowel disease enterocutaneous fistulas. Int J Surg. 41:127–133.
   PubMed Web of Science ®Google Scholar
• Reboredo, M. M., B. V. Pinheiro, and J. M. Chebli. 2017. Physical exercise programs in patients with inflammatory bowel disease. J Crohns Colitis. 22
   Google Scholar
• Reich, K. M., R. N. Fedorak, K. Madsen, and K. I. Kroeker. 2014. Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review. World J Gastroenterol. 20:4934–47.
   PubMed Web of Science ®Google Scholar
• Rosen, M. J., A. Dhawan, and S. A. Saeed. 2015. Inflammatory bowel disease in children and adolescents. JAMA Pediatr. 169:1053–60.
   PubMed Web of Science ®Google Scholar
• Ryz, N. R., A. Lochner, and K. Bhullar. 2015. Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis. Am J Physiol Gastrointest Liver Physiol. 309(9):G730–42. doi: 10.1152/ajpgi.00006.2015.
   PubMed Web of Science ®Google Scholar
• Santos-Antunes, J., A. C. Nunes, S. Lopes, and G. Macedo. 2016. The Relevance of Vitamin D and Antinuclear Antibodies in Patients with Inflammatory Bowel Disease Under Anti-TNF Treatment: A Prospective Study. Inflamm Bowel Dis. 22:1101–6.
   PubMed Web of Science ®Google Scholar
• Sharma, L. K., D. Dutta, N. Sharma, and A. K. Gadpayle. 2017. The increasing problem of subclinical and overt hypervitaminosis D in India: An institutional experience and review. Nutrition. 34:76–81.
   PubMed Web of Science ®Google Scholar
• Simek, R. Z., J. Prince, S. Syed, C. G. Sauer, B. Martineau, T. Hofmekler, A. J. Freeman, A. Kumar, B. O. McElhanon, B. T. Schoen, G. Tenjarla, C. McCracken, T. R. Ziegler, V. Tangpricha, and S. Kugathasan. 2016. Pilot Study Evaluating Efficacy of 2 Regimens for Hypovitaminosis D Repletion in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 62:252–8.
   PubMed Web of Science ®Google Scholar
• Torki, M., A. Gholamrezaei, L. Mirbagher, M. Danesh, S. Kheiri, and M. H. Emami. 2015. Vitamin D Deficiency Associated with Disease Activity in Patients with Inflammatory Bowel Diseases. Dig Dis Sci. 60:3085–91.
   PubMed Web of Science ®Google Scholar
• Travassos, L. H., L. A. Carneiro, M. Ramjeet, S. Hussey, Y. G. Kim, J. G. Magalhães, L. Yuan, F. Soares, E. Chea, and L. Le Bourhis. 2010. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 11:55–62.
   PubMed Web of Science ®Google Scholar
• Ulitsky, A., A. N. Ananthakrishnan, A. Naik, S. Skaros, Y. Zadvornova, D. G. Binion, and M. Issa. 2011. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 35:308–16.
   PubMed Web of Science ®Google Scholar
• Verway, M., M. Bouttier, T. T. Wang, M. Carrier, M. Calderon, B. S. An, E. Devemy, F. McIntosh, M. Divangahi, and M. A. Behr. 2013. Vitamin D Induces Interleukin-1 beta Expression: Paracrine Macrophage Epithelial Signaling Controls M-tuberculosis Infection. Plos Pathogens. 9:e1003407.
   PubMed Web of Science ®Google Scholar
• Wang, J., L. B. Thingholm, J. Skiecevičienė, and P. Rausch. 2016. Genome-wide association analysis identifies variation in vitamin D receptor and otherhost factors influencing the gut microbiota. Nat Genet. 48:1396–1406.
   PubMed Web of Science ®Google Scholar
• Wang, T. T., B. Dabbas, D. Laperriere, A. J. Bitton, H. Soualhine, L. E. Tavera-Mendoza, S. Dionne, M. J. Servant, A. Bitton, and E. G. Seidman. 2010. Direct and Indirect Induction by 1,25- Dihydroxyvitamin D3 of the NOD2/CARD15-Defensin β2 Innate Immune Pathway Defective in Crohn Disease. Journal of Biological Chemistry. 285:2227–2231.
   PubMed Web of Science ®Google Scholar
• White, J. H. 2016. Vitamin D deficiency and the pathogenesis of Crohn's disease. J Steroid Biochem Mol Biol. 23. pii: S0960-0760(16)30361-2
   Google Scholar
• Winter, R. W., E. Collins, B. Cao, M. Carrellas, A. M. Crowell, and J. R. Korzenik. 2017. Higher. 25-hydroxyvitamin D levels are associated with greater odds of remission with anti-tumour necrosis factor-α medications among patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 45:653–659.
   PubMed Web of Science ®Google Scholar
• Yang, W. S., J. J. Kim, N. J. Han, E. K. Lee, and S. K. Park. 2017. 1,25-Dihydroxyvitamin D3 Attenuates the Effects of Lipopolysaccharide by Causing ADAM10-Dependent Ectodomain Shedding of Toll-Like Receptor 4. Cell Physiol Biochem. 41:2104–2116.
   PubMed Web of Science ®Google Scholar
• Yano, T., and S. Kurat,a. 2011. Intracellular recognition of pathogens and autophagy as an innate immune host defence. J Biochem. 150:143–9.
   PubMed Web of Science ®Google Scholar
• Yokota, H., A. Tsuzuki, Y. Shimada, A. Imai, D. Utsumi, T. Tsukahara, M. Matsumoto, K. Amagase, K. Iwata, A. Nakamura, C. Yabe-Nishimura, and S. Kato. 2017. NOX1/NADPH Oxidase Expressed in Colonic Macrophages Contributes to the Pathogenesis of Colonic Inflammation in Trinitrobenzene Sulfonic Acid-Induced Murine Colitis. J Pharmacol Exp Ther. 360:192–200.
   PubMedGoogle Scholar
• Zator, Z. A., S. M. Cantu, G. G. Konijeti, D. D. Nguyen, J. Sauk, V. Yajnik, and A. N. Ananthakrishnan. 2014. Pretreatment 25-Hydroxyvitamin D Levels and Durability of Anti-Tumor Necrosis Factor-alpha Therapy in Inflammatory Bowel Diseases. JPEN J Parenter Enteral Nutr. 38:385–91.
   PubMed Web of Science ®Google Scholar
• Zheng, M. K., D. Q. Shih, and G. C. Chen. 2017. Insights on the use of biosimilars in the treatment of inflammatory bowel disease. World J Gastroenterol. 3:1932–1943.
   Google Scholar
• Zhiwei, Liu., Kong Fansheng, E. Jefferson, E. Vallance, Surya Harmel‐Laws, and Kris A. Amarachintha. 2017. Steinbrecher, Michael J. Rosen, Sandip Bhattacharyya. Activation of TGF‐β activated kinase 1 promotes colon mucosal pathogenesis in inflammatory bowel disease. Physiological Reports Published. 5:e13181.
   PubMed Web of Science ®Google Scholar